A B S T R A C T Onset of lung edema is usually associated with increase in the pulmonary transvascular flux of water and proteins. Clinical measurement of these parameters may aid in early diagnosis of pulmonary edema, and allow differentiation between "cardiogenic" and "noncardiogenic" types based on the magnitude of the detected changes. We have previously described a noninvasive method for estimating transvascular protein flux in lung (Gorin, A. B., W. J. Weidner, R. H. Demling, and N. C. Staub. 1978 . Noninvasive measurement of pulmonary transvascular protein flux in sheep. J. . Using this method, we measured the net transvascular flux of [ll3mIn]transferrin (mol wt, 76,000) T/2 = 7.0+2.6 h (mean± SD). The pulmonary transvascular flux coefficient, a, was 2.9±1.4 x 10-3 ml/s (mean +SD) in man, slightly greater than that previously measured in sheep (2.7±0.7 x 10-3 ml/s; mean+SD).
A B S T R A C T Onset of lung edema is usually associated with increase in the pulmonary transvascular flux of water and proteins. Clinical measurement of these parameters may aid in early diagnosis of pulmonary edema, and allow differentiation between "cardiogenic" and "noncardiogenic" types based on the magnitude of the detected changes. We have previously described a noninvasive method for estimating transvascular protein flux in lung (Gorin, The pulmonary transcapillary escape rate is twofold greater than the transcapillary escape rate for the vascular bed as a whole, indicating a greater "porosity" of exchanging vessels in the lung than exists for the "average" microvessel in the body. Time taken to reach half-equilibrium concentration of tracer protein in the lung interstitium was quite short, 52+13 min (meantSD).
We have shown that measurement of pulmonary transvascular protein flux in man is practical. The coefficient of variation of measurements of a (between subjects) was 0.48, and of measurements of pulmonary transcapillary escape rates was 0.39. In animals, endo-
INTRODUCTION
The water capacitance of the lung always exceeds its normal water content. Considerable increase in extravascular lung water can occur before flooding ofalveoli results in disturbance of respiratory gas exchange (1) . During this period of interstitial water filling, detection of pulmonary edema would allow early and aggressive therapy before the appearance of significant clinical symptoms.
Onset of lung edema is usually associated with increase in the pulmonary transvascular flux of water and proteins. In typical "cardiogenic" pulmonary edema, recruitment of capillary bed results in an increased surface area available for macromolecular flux, whereas an increase in convective forces leads to greater flux per unit surface area (2) (3) (4) . In "noncardiogenic" pulmonary edema, a "capillary-leak syndrome," with impairment of the normal molecular sieving function of the endothelial membrane, results in veritable "flooding" of the interstitium with oncotically active proteins (5) (6) (7) . Clinical measurement of transvascular protein flux in lung may aid in early diagnosis of pulmonary edema, and allow differentiation between "cardiogenic" and "noneardiogenic" types based on the magnitude of detected changes.
We have previously described a noninvasive method for estimating transvascular protein flux in the lung (8) . The The flux between compartments occurs at a rate far in excess of that for metabolic degradation in either, and a dynamic equilibrium is eventually reached.
A scintillation detection unit (probe) externally positioned over the lung must measure input from tracer in both compartments; a venous sample of whole blood (WB) taken simultaneously and counted in a well counter will measure input only from one (IV). By also using a marker restricted to the IV compartment (R) it is possible to partition the probe input by use of the following relationship.
DiVe ( Radiopharmaceuticals. Autologous RBC were labeled with "mTc (half-life, 6 h) by the method of Korubin et al. (9) . Heparinized plasma, saved from the initial cell separation, was labeled in vitro with 3"'mIn (half-life, 100 min) by dropwise addition to the sterile eluate of an Indium generator (New England Nuclear, Boston, Mass.). Indium binds with high specificity to transferrin, a ,-globulin (mol wt, 76,000). All agents were prepared using aseptic techniques in the 870
A. B. Gorin, J. Kohler, and G. DeNardo radiopharmacy of the Nuclear Medicine Section, University of California Davis Medical Center. Protocol. Subjects were studied supine. A scintillation detection probe was positioned over the right midlung field (-T-6 level) or the left lung apex (-T-4 level). 3-5 mCi ofautologous 9"-Tc-RBC were given as an intravenous bolus and 10 min was allowed for dispersion in the vascular space. We then gave 5-10 mCi autologous [l13mIn]transferrin ([ll3mIn]Tf) as a bolus injection at the same site (to). An intravenous heparin lock was placed in the opposite arm and 3-ml WB were drawn at 10-min intervals during the next 60 min. Sequential 50-s counts of gamma emissions from both isotopes were made over the lung for periods of 60-90 min.
Special instrumentation. We performed these studies using any one (or two) of three different scintillation detection probes: (a) 3 x 2 in. NaI crystal (Nuclear Chicago, Des Plaines, Ill.), fitted with a multi-hole collimator focused to a field 4 cm Diam at a point 14 cm from the collimator face (8, complete description of collimator response); (b) 2 x 2 in. Nal crystal (Nuclear Chicago) fitted with a single-channel, diverging collimator (two of these units were available); (c) 2 x 2 in. Nal crystal (ADAC Laboratories, Sunnyvale, Calif.), fitted with a single-channel, (2 in. Diam) parallel wall collimator.
The signal output from the probes was processed by a computer-based multichannel-analyzer (TN-11 system, Tracor/Northern, Middleton, Wis.). Thus, we were able to continuously sample the entire spectrum of photon energies between 0 and 1,000 keV. During the 50-s counting periods, accumulating y-emissions were displayed on a 6 in. cathoderay tube (CRT) screen. Two peaks, representing the monoenergic photons of 9"'Tc (140 keV) and 13mIn (390 keV), are clearly seen to emerge above background radiation ( Fig. 1) . At the end ofeach 50-s interval ofdata acquisition, background radiation was stripped from the data, the area under the upper peak (la3mIn emissions) integrated, the H13mIn emissions (including Compton scattered radiation) stripped from the data, and the area under the lower peak ('*mTc emissions) integrated ( (background and pure ll3mIn) obtained before administration of the radiopharmaceuticals and stored on floppy disk. ll3mIn and "mTc count rates were then corrected for radioactive decay to equivalent count rates at to. These operations were performed automatically by a PDP 11/10 computer, 32K core (Digital Equipment Corp., Marlboro, Mass.) around which the TN-11 system is assembled. The corrected count rates, real time of data acquisition, and time elapsed from to were then simultaneously stored in computer memory and printed via an ASR-33 teletype terminal (Teletype Corp., Skokie, Ill.). The sequence of data acquisition and processing took between 1.5 and 2.5 min.
At the end of each study, all data points for each radiotracer over time could be displayed on the CRT screen (Fig.  2) . Radioactivity of the patient's WB was then determined using a Nal well counter. The output signal of this unit was also processed by the multichannel analyzer in a fashion identical to that used for the signal from the external probes.
Data analysis. We weighed the WB counted in the well counter, determined the hematocrit of the sample, and expressed ll3mIn activity as counts per minute per gram plasma. The decrease in plasma concentration of diffusible tracer over the time of the study is well fit by an exponential regression:
The time constant (K') a function of the plasma clearance of the diffusible tracer protein, is frequently called the "transcapillary escape rate" (TCER) (10) .
99mTc activity in whole blood falls slowly as RBC damaged in the labeling procedure are sequestered in the spleen, and the radiolabel elutes from the RBC. The ratio of 'l3mIn activity to 99mTc activity in whole blood is a decreasing monotonic function (Fig. 3) . Again, the data is well fit by an exponential regression:
113n InwBt, (counts per minute/gram) -xt, "mTCWBIl (counts per minute/gram) where a = DwB/RWB at to (4) In these studies, the externally detected count rate for "mTc over lung either remained constant, or fell slightly over time, reflecting a decrease in regional pulmonary blood volume. The rate of macromolecular efflux from the pulmonary microcirculation is relatively greater than that from the vascular compartment as a whole (11, 12 The derivation of Eq. 7 is given in a previous publication (8) . 1 The compartmental system used is schematized in Fig. 5 The first derivative of Eq. 7 will equal zero when no net exchange of tracer protein occurs between IV and EV compartments. At that time, the lung interstitial concentration of tracer protein will be at its maximum value, and thereafter will decline along a single exponential. The time taken to reach maximum tracer concentration in the lung interstitium (te) is given by ln /'/K' te P -K lo?
106 ( 8) Insertion of te for t, in Eq. 7 allows us to calculate the value of DEVe at te. Eq. 7 can then be used to determine time to halfmaximum tracer concentration in the pulmonary interstitium (t4,2).
Whole lung values. The scintillation detection probes used in these studies all had a collimated field of view, and so detected y-emissions from only a fraction of the total lung mass. Thus, the absolute value of a is highly idiosyncratic and depends upon the characteristics of the scintillation detection system and the tissue traversed by y-emissions. The volume of lung sampled varied from probe to probe, and with placement ofany given probe ( [8] and see below for discussion of the effect of including nonlung tissue in the sampled field). Pulmonary transvacular protein flux, a, is a function of both vascular permeability and the surface area available for macromolecular exchange. The exchanging surface area should vary directly with the volume of lung tissue in the collimated field. Therefore, measurements ofa made with two different probes, or even with the same probe on two different occasions, are not directly comparable unless normalized in some manner for the volume of tissue sampled in the study.
As the volume of lung tissue in the field varies, the regional pulmonary blood volume (PBV,) also increases or decreases. Thus, data obtained using highly focused and widely open collimators can be compared by dividing a (milliliters/time) by PBV, (milliliters). a/PBV, (time-') is a time constant. If regional pulmonary plasma volume (PPV,) is used in the denominator, rather than PBV, the resulting time constant is a pulmonary TCER comparable to TCER. In any study, subtracting measured DEVe from Dive at each t1 (analagous to subtracting lymph from plasma concentrations of diffusible tracer) yields a monotonic decreasing exponential function (Fig. 6) throughout the lung, we can extrapolate from our regional data to whole lung values of a(aT). In the whole lung, the slope of IVe -EVe over time will be the same as in the region we are sampling, but the intercept at to will equal the mass of diffusible tracer in the exchanging vessels of the entire lung at to. We assumed that this whole lung intercept value was equal to the activity in blood at to (known from the whole blood samples) multiplied by the pulmonary capillary blood volume (Vc) measured by the method of Roughton and Forster (14) (Fig. 6 ).
RESULTS
Data from 14 studies are shown in Tables I and II Thus, Vp(e-K't -e-wt) = a (e-K'ti e-t'). (12) /3 -KI If w /3', then Vp(w -K') = a.
This latter technique was used to estimate the bracketed values of a, /' and t1/2 entered in Tables I and II. In Fig. 7 , we compare values of a/PPV obtained by the iterative process and by graphic solution in the other 11 studies. In normal man, the graphic method yields a good approximation of a. Unfortunately, this simple altemative yields a poor estimate of /' (,/' graph = 7.685 x 10 -0.210 computer; r = -0.44; Discussion).
After administration of [ll3mIn]Tf as an intravenous bolus, some finite time is required for uniform dispersion of the tracer in the vascular space (mixing time). During this early period, [113In]Tfactivity in peripheral venous samples may not reflect activity in the central blood volume. Drawing two or three samples at 3-min intervals after the bolus administration of [113mIn]Tf, we empirically found that the mixing phase lasted between 5 and 7 min in our subjects. Therefore, counts detected over the lung during the first 7 min after tracer injection were not used in estimating param- eters. Vc = 73±8 cm3 (mean± SD) in the nine subjects.
DISCUSSION
We have measured pulmonary transvascular protein flux in normal man using a noninvasive method, external radioflux detection. No previous assessments, direct or indirect, of this parameter have been reported in man. In an earlier publication (8) , we demonstrated the validity and sensitivity of this technique by correlating our noninvasive determination of interstitial accumulation of tracer protein with the directly measured accumulation in lung lymph of sheep.
The estimates of TCER (K') and time to reach one- such as skin and muscle (which comprise the majority of body mass) (11, 12, 19, 20 (12, 19, 21) .
We have previously discussed sources of variability or error in measurement of pulmonary transvascular protein flux by the external radioflux detection method (8) . Two areas require additional discussion in the light of the present data.
(a) We assumed that all externally detected radioactivity originates in lung. Actually, both isotopic markers are widely distributed. We have contended that because this noninvasive method is sensitive to the rate at which il3mIn counts accumulate in the EV space, rather than the absolute count rate, it will be little affected by the slow flux of macromolecules into chest wall tissue. This argument is more valid given the very rapid tl/2 for tracer equilibration seen in human lung.
Additionally, we have now studied subjects using both a focused collimator, designed to minimize detection of counts arising in the chest wall, and "wideopen" collimators. In Fig. 8 a/PBV, min-'x1O0 FIGuRE 8 Correlation of replicate measurements of a (normalized to PBV). In control subjects, the measurements were made at an interval of at least 6 mo. The first measurement (abscissa) was made using a single-channel, diverging collimator. The second measurement was made using a multihole focussed collimator. In the four patient studies, probes with single-channel diverging collimators were placed over a right and a left lung field, and the two measurements were obtained simultaneously. One patient (a/PBV -5) had congestive heart failure, and the final patient had a bronchopneumonia. The line drawn is that of identity. 60 min of study, and is also an index of the reliability of this measurement. We now recommend use of a multi-hole parallel channel collimator to adequately limit the field of view of the detector laterally, while still retaining a very high sensitivity (high geometric efficiency).
(b) We extrapolate from measurements made in a small core of lung tissue to events occurring in the entire lung. Obviously, extension from part to whole depends on the homogeneity of transvascular protein flux across the lung. We studied subjects supine, rather than upright, to minimize zonal effects in the distribution of perfusion to lung regions (22, 23) .
A graphic method has been used both to extrapolate from regional to whole organ data, and to estimate regional parameters (a and ,') in a small group of studies which could not be analyzed using the customary iterative process. We have shown that in normal subjects the graphic method yields a good estimate of a for the region being sampled. The actual value ofthe computed aT depends largely on the assumed volume of the vascular compartment in the lung exchanging with the interstitial space. We used Vc in our calculations because this could be independently measured in each subject. Vc determined by the method of Roughton and Forster, 1957 , may vary from anatomic pulmonary Vc (measured morphometrically) by a factor of 2 (24) . Presumably, this relates to areas of the lung that are not ventilated but are either perfused or have static blood volumes (25) . Although it is unlikely that static blood volume would be a site of transvascular protein flux, use of Vc may lead to systematic underestimation of the intravascular exchanging volume, and thus a systematic error in the extrapolation to aT. This is difficult to assess in the absence of direct access to lung lymph in man.
The coefficient of variation in measurements of aT (between subjects) was 0.48. This is greater than that noted in sheep (0.23). In our animal studies, measurements were made using the same collimator-detector unit in every case, and sampling a small core of tissue in exactly the same location in each sheep. Calculation of the whole lung parameter for a involved an assumed compartment volume. In man, extrapolation from regional to whole lung data combines the variability of external radioflux detection with the variability of Vc determination. Measurement of pulmonary transcapillary escape rate, alPPV, involving only external radioflux detection, had a coefficient of variation of 0.39. This variability may in part be attributed to the variety of collimator-detector units used in making these measurements, and to some regional variation in transvascular protein exchange.
In sheep, endothelial injury in the lung typically causes at least a two-to threefold increase in transvascular protein flux (5, 8, 26 ). Yet, significant pulmonary edema is rarely seen with an insult of this magnitude (26) . Presumably, even a greater increase in transendothelial protein flux must occur before the "pulmonary edema safety factors" in lung are overwhelmed. Thus, the sensitivity of external radioflux detection in man is such that it should detect all clinically significant changes in pulmonary transvascular protein flux.
We have used external radioflux detection to measure pulmonary transvascular protein flux in man. The method is minimally invasive, and in our recent studies, using the ADAC probe, total radiation dose to the subject is only 115 mrad. We have demonstrated the validity of the method in suitable animal models (8) . In 1979, Prichard and Lee (27) successfully used a similar approach to assess vascular permeability in the dog lung. Although the actual value of a will vary with placement ofthe detector, or the specific detectors used, we have described two means of normalizing data which makes possible comparisons of data obtained in different laboatories or 
